Rye Brook Capital LLC Acquires New Position in iShares Biotechnology ETF (NASDAQ:IBB)

Rye Brook Capital LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 21,300 shares of the financial services provider’s stock, valued at approximately $2,816,000. iShares Biotechnology ETF makes up approximately 3.4% of Rye Brook Capital LLC’s portfolio, making the stock its 10th biggest holding.

Other institutional investors have also modified their holdings of the company. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter worth about $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth $30,000. HHM Wealth Advisors LLC raised its stake in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares during the last quarter. Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $33,000. Finally, Hager Investment Management Services LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.4 %

IBB stock opened at $137.11 on Wednesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The stock’s 50 day moving average price is $135.55 and its 200 day moving average price is $140.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.